Agent |
Dosage | |
Acute pericarditis |
Recurrent pericarditis | |
ASA |
650-1000 mg every 6-8 ha,b |
500-1000 mg every 6-8 h (1.5-4 g/d)b,c |
Ibuprofen |
600-800 mg every 8 ha,d |
600 mg every 8 h (1200-2400 mg)b,c |
Colchicine |
0.5-0.6 mg (once dailye or bidf)g,h |
0.5-0.6 mg (bidf or once dailye,i)h,j |
Indomethacin |
– |
25-50 mg every 8 hc,k,l |
Glucocorticoids |
Doses depend on agents usedm,n | |
a For 1-2 weeks. b Decrease the dose by 250-500 mg every 1-2 weeks. In case of recurrent pericarditis in patients showing more resistance to treatment, you may consider more gradual and longer tapering of doses down to discontinuation. c For weeks or months. d Decrease the dose by 200-400 mg every 1-2 weeks. In case of recurrent pericarditis in patients showing more resistance to treatment, you may consider more gradual and longer tapering of doses down to discontinuation. e In patients <70 kg. f In patients ≥70 kg. g For 3 months. Note that in North America colchicine is only available in 0.6 mg tablets, whereas the 0.5 mg dose is available in Europe. h Tapering down is not necessary; however, you may decrease the dose by 0.5 mg every other day in patients <70 kg or by 0.5 mg once a day in the last weeks of treatment in patients ≥70 kg. i In patients who do not tolerate higher doses. j For ≥6 months. k Start from low doses and titrate them up to avoid headache and dizziness. l Decrease the dose by 25 mg every 1-2 weeks. In patients resistant to treatment, you may consider more gradual and longer tapering of doses down to discontinuation. m The starting dose of prednisone is 0.25-0.5 mg/kg/d. A dose of 25 mg of prednisone is equivalent to 20 mg of methylprednisolone. Higher doses should be avoided except for selected patients (higher doses are then used over a few days and rapidly tapered down to 25 mg/d). n Prednisone dose may be tapered down (particularly <25 mg/d) when symptoms have resolved and CRP has normalized. | ||
Based on Eur Heart J. 2015;36(42):2921-64. | ||
ASA, acetylsalicylic acid; bid, twice a day; CRP, C-reactive protein. |